Save on Cancer Medications from Canada: Sprycel and the Introduction of Generic Dasatinib in the United States and Canada
Sprycel (dasatinib), developed by Bristol Myers Squibb, is tyrosine kinase inhibitor approved by the FDA on June 28, 2006, for…
Sprycel (dasatinib), developed by Bristol Myers Squibb, is tyrosine kinase inhibitor approved by the FDA on June 28, 2006, for…
Attention Americans: Mounjaro, a popular medication for managing type 2 diabetes, has recently launched KwikPens in Canada, adding to the…
The Food and Administration (FDA) has authorized use of Ozempic (semaglutide) for the treatment of chronic kidney disease (CKD) in adults…
Key Points A prescription that improves sleep, without the need for surgery or CPAP. It helps improve sleep quality, providing…
Norovirus, sometimes referred to as the “Winter vomiting bug,” has been making waves across the U.S., prompting concerns about its…